Product NDC: | 51672-2027 |
Proprietary Name: | Triple Antibiotic Plus Pain Relief |
Non Proprietary Name: | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride |
Active Ingredient(s): | 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g & nbsp; Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-2027 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part333B |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120331 |
Package NDC: | 51672-2027-2 |
Package Description: | 1 TUBE in 1 CARTON (51672-2027-2) > 28.4 g in 1 TUBE |
NDC Code | 51672-2027-2 |
Proprietary Name | Triple Antibiotic Plus Pain Relief |
Package Description | 1 TUBE in 1 CARTON (51672-2027-2) > 28.4 g in 1 TUBE |
Product NDC | 51672-2027 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20120331 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE |
Strength Number | 500; 3.5; 10000; 10 |
Strength Unit | [USP'U]/g; mg/g; [USP'U]/g; mg/g |
Pharmaceutical Classes |